Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISAL 2023 | The importance of fitness assessment to improve treatment selection in patients with AML

Raffaele Palmieri • 20 Mar 2023
ISAL 2023
Acute Myeloid Leukemia Leukemia

Raffaele Palmieri, MD, University of Rome “Tor Vergata”, Rome, Italy, explains how assessing patient fitness is crucial to select the best course of treatment in acute myeloid leukemia (AML). This interview took place at the 18th International Symposium on Acute Leukemias (ISAL XVIII), held in Munich, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Raffaele Palmieri

1:55
GIMEMA AML1310: 6-year follow-up results
Raffaele Palmieri • 20 Mar 2023
1:05
Identifying residual LSCs that may evade standard MRD monitoring & lead to relapse in AML
Raffaele Palmieri • 20 Mar 2023

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals